Business Description
Alpa Laboratories Ltd
ISIN : INE385I01010
Total Employee Number:
453Compare
Compare
Traded in other countries / regions
532878.India IPO Date
2007-08-06Description
Alpa Laboratories Ltd is an India-based pharmaceutical company. It operates in the drug and chemical business segment. The company manufactures and markets pharmaceuticals and related products. It sells products like liquid injection, dry powder injection, tablets, capsules, and ointments.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 56.15 | |||||
Equity-to-Asset | 0.77 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | 0.13 | |||||
Interest Coverage | 4.65 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 3.01 | |||||
Beneish M-Score | -2.32 | |||||
WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 4.6 | |||||
3-Year EBITDA Growth Rate | 3.3 | |||||
3-Year EPS without NRI Growth Rate | 12.9 | |||||
3-Year FCF Growth Rate | -8.3 | |||||
3-Year Book Growth Rate | 11.4 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 47.59 | |||||
9-Day RSI | 47.64 | |||||
14-Day RSI | 48.49 | |||||
3-1 Month Momentum % | -1.51 | |||||
6-1 Month Momentum % | -9.6 | |||||
12-1 Month Momentum % | -33.92 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 4.01 | |||||
Quick Ratio | 3.76 | |||||
Cash Ratio | 2.68 | |||||
Days Inventory | 77.64 | |||||
Days Sales Outstanding | 143.07 | |||||
Days Payable | 98.51 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shareholder Yield % | -0.94 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 29.78 | |||||
Operating Margin % | 1.13 | |||||
Net Margin % | 14.33 | |||||
EBITDA Margin % | 18 | |||||
FCF Margin % | 5.67 | |||||
OCF Margin % | 9.4 | |||||
ROE % | 8.41 | |||||
ROA % | 6.48 | |||||
ROIC % | 1.33 | |||||
3-Year ROIIC % | -36.29 | |||||
ROC (Joel Greenblatt) % | 39.78 | |||||
ROCE % | 9.19 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 10.14 | |||||
PE Ratio without NRI | 10.14 | |||||
Shiller PE Ratio | 12.27 | |||||
Price-to-Owner-Earnings | 7.18 | |||||
PEG Ratio | 0.98 | |||||
PS Ratio | 1.39 | |||||
PB Ratio | 0.78 | |||||
Price-to-Tangible-Book | 0.78 | |||||
Price-to-Free-Cash-Flow | 24.13 | |||||
Price-to-Operating-Cash-Flow | 14.54 | |||||
EV-to-EBIT | 0.38 | |||||
EV-to-EBITDA | 0.34 | |||||
EV-to-Revenue | 0.06 | |||||
EV-to-FCF | 1.07 | |||||
Price-to-GF-Value | 0.73 | |||||
Price-to-Projected-FCF | 0.74 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.71 | |||||
Price-to-Graham-Number | 0.59 | |||||
| Price-to-Net-Current-Asset-Value | 0.93 | |||||
| Price-to-Net-Cash | 1.7 | |||||
Earnings Yield (Greenblatt) % | 263.16 | |||||
FCF Yield % | 4.14 | |||||
Forward Rate of Return (Yacktman) % | 11.38 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Alpa Laboratories Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 1,058.096 | ||
| EPS (TTM) (₹) | 6.78 | ||
| Beta | 2.1908 | ||
| 3-Year Sharpe Ratio | 0.06 | ||
| 3-Year Sortino Ratio | 0.1 | ||
| Volatility % | 58.96 | ||
| 14-Day RSI | 48.49 | ||
| 14-Day ATR (₹) | 2.308735 | ||
| 20-Day SMA (₹) | 68.5985 | ||
| 12-1 Month Momentum % | -33.92 | ||
| 52-Week Range (₹) | 46.1 - 105.9 | ||
| Shares Outstanding (Mil) | 21.04 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Alpa Laboratories Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Alpa Laboratories Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Alpa Laboratories Ltd Frequently Asked Questions
What is Alpa Laboratories Ltd(NSE:ALPA)'s stock price today?
The current price of NSE:ALPA is ₹68.25. The 52 week high of NSE:ALPA is ₹105.90 and 52 week low is ₹46.10.
When is next earnings date of Alpa Laboratories Ltd(NSE:ALPA)?
The next earnings date of Alpa Laboratories Ltd(NSE:ALPA) is .
Does Alpa Laboratories Ltd(NSE:ALPA) pay dividends? If so, how much?
Alpa Laboratories Ltd(NSE:ALPA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Alpa Laboratories Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers